Understand the study
Oxytocin and Appetite: Why Eating Less Did Not Mean Weight Loss
Read a test-meal result alongside the trial’s main eight-week weight result.
What did the trial want to know?
Earlier appetite findings motivated a human trial, but its main question was body-weight change after eight weeks. Sixty-one adults with obesity were randomized to an intranasal oxytocin preparation or placebo. A main question is chosen in advance so that the final story cannot simply follow whichever measurement looks best. [1]
What was the main result?
The reported average changes were +0.20 kg with oxytocin and +0.26 kg with placebo, without a significant difference. The trial therefore did not show weight reduction from the tested approach. A result from another measurement does not replace this answer to the main question. [1]
- 01One test meal
- 02Eight-week weight
- 03Two different questions
Why did the meal result sound positive?
At an experimental meal, caloric-intake change differed between groups by about −152 kcal. This was a secondary outcome, and the paper notes that these analyses did not correct for multiple comparisons. It should be treated as an exploratory finding, not proof of an appetite treatment effect. [1]
Why can one meal and eight weeks differ?
A test meal is a snapshot. Body weight reflects changes accumulated over a much longer period. One meal cannot tell us everything eaten or expended between visits. As a simple analogy, spending less on one purchase does not prove that total monthly spending fell. The study needs the long-term measurement to answer the weight question.
Does “not significant” mean no biological activity?
That would be too broad. The trial answers a defined question about a particular preparation, population and period. It does not prove every oxytocin research question is false. Equally, biological plausibility cannot be used to erase the negative weight result. Keep what was measured separate from what is still a hypothesis.
How is the catalog material related?
The link below is for Oxytocin Acetate research material. It is not the intranasal clinical formulation and the trial supplies no use instructions for that material. Describe the laboratory target and required records when making an inquiry, rather than assuming that an appetite headline establishes product suitability.
Explore the research topic
Related research products
Oxytocin Acetate
Weight and metabolism research
View product
Kisspeptin-10
Weight and metabolism research
View product
Gonadorelin Acetate
Weight and metabolism research
View productImages illustrate the catalog. Related products are further reading, not claims of equal effects or interchangeability.
Original research and reading notes
Study amounts and preparations identify experimental conditions, not recommended use. AI-assisted research explanation; sources checked 11 October 2026. NHD catalog materials are for research, development and manufacturing, not human or veterinary use.